Shiwei Li

机构：Tianjin Medical University General Hospital, Jilin Jianzhu University, Apple (United Kingdom), Tianjin Medical University · ORCID：0000-0002-7506-5779

发表论文 31 篇 · 总被引 601 次 · h-index 12

代表论文

• Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway (2022 · International Journal of Biological Sciences · 被引 125)
• Safety and Efficacy of Remote Ischemic Conditioning in Patients With Intravenous Thrombolysis: The SERIC-IVT Trial (2025 · Stroke · 被引 20)
• LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth (2021 · Cell Cycle · 被引 18)
• Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein (2021 · Acta Cirúrgica Brasileira · 被引 17)
• Transcriptome Profiling Identifies Differentially Expressed Genes in Skeletal Muscle Development in Native Chinese Ducks (2023 · Genes · 被引 13)
• Vitamin D can mitigate sepsis-associated neurodegeneration by inhibiting exogenous histone-induced pyroptosis and ferroptosis: Implications for brain protection and cognitive preservation (2024 · Brain Behavior and Immunity · 被引 12)